XML 136 R113.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Restricted Stock Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 05, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restricted Stock        
Restricted Stock, Shares        
Beginning balance (in shares)   182,446    
Granted (in shares)   230,141    
Exercised (in shares)   (197,765)    
Forfeited (in shares)   (2,742)    
Ending balance (in shares)   212,080 182,446  
Restricted Stock, Weighted-Average Grant Date Fair Value        
Beginning balance (in dollars per share)   $ 42.09    
Granted (in dollars per share)   41.98 $ 41.04 $ 43.48
Exercised (in dollars per share)   43.98    
Forfeited (in dollars per share)   42.89    
Ending balance (in dollars per share)   40.33 42.09  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Weighted-average grant date fair value (in dollars per share)   $ 41.98 $ 41.04 $ 43.48
Total fair value of restricted shares that vested   $ 8,698 $ 7,368 $ 8,617
Nonvested (in shares)   212,080 182,446  
Restricted Stock | Retention Agreement | Share-Based Payment Arrangement, Tranche One        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Vesting period for awards 24 months      
Restricted Stock | Retention Agreement | Share-Based Payment Arrangement, Tranche Two        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Vesting period for awards 6 months      
Restricted Stock | Chairman And Chief Executive Officer | Retention Agreement        
Restricted Stock, Shares        
Ending balance (in shares) 26,766      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Nonvested (in shares) 26,766      
Restricted Stock | Senior Vice President And General Counsel | Retention Agreement        
Restricted Stock, Shares        
Ending balance (in shares) 8,922      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Nonvested (in shares) 8,922      
Performance Shares | Executive        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Shares excluded in year two (in shares)     140,882  
Shares excluded in year three (in shares)       139,242
Performance period   3 years    
Performance Shares | Executive | Achieved Performance Target For 2018 Through 2020        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Shares excluded (in shares)   100,991    
Performance Shares | Executive | Achieved Performance Target for 2019 - 2021        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Shares excluded (in shares)   80,492